Abstract

Objective: To investigate the release of bone morphogenetic protein-2 (BMP-2) and collagen type I proteins (COL1) from different sources ofdemineralized dentine matrix (DDM) and their chemotaxis to mouse osteoprogenitor cells.Methods: The release kinetic of BMP-2 and COL1 was measured from custom-made DDM (CMDDM) and commercially available DDM (CADDM).Using Urist physicochemical method, CMDDM was collected from the extracted teeth in a certified dental clinic. Levels of BMP-2 and COL1 releasedwere measured at days 1, 2, 3, 5, 7, 9, 11, and 13. Next, mouse osteoprogenitor cells, MC3T3-E1, were cultured with a variety of materials as follows:CMDDM, CADDM, Bio-Oss®, and blank control in transwell system. The number of cell migration was determined by crystal violet staining to explorechemotaxis of different DDMs to mouse osteoprogenitor cells.Results: BMP-2 was detected at 588.32 ± 14.53 pg/ml from 5 g of CMDDM. In the release kinetic assay, the concentration of BMP-2 in the CMDDMgroup increased rapidly and peaked at 113.9 pg/ml on day 5, almost four times higher than that of CADDM. The release of COL1 showed similarpattern in both CMDDM and CADDM; however, the amount was significantly higher in the CMDDM group. In cell culture experiment, the number ofmigrated MC3T3-E1 was ranked as the highest in CMDDM, followed by CADDM and Bio-Oss® (p<0.05).Conclusion: CMDDM released BMP-2 and COL1 greater than CADDM, which can induce more osteoblast-like cell migration. These results demonstrateda release kinetic of proteins and osteoinductivity of CMDDM, which supports a benefit of using autogenous bone graft.

Highlights

  • Every year, an estimated 2 million individuals worldwide suffer from bone defects due to trauma, infection, tumor, or congenital hereditary diseases caused by bony abnormalities

  • custom-made DDM (CMDDM) released bone morphogenetic protein-2 (BMP-2) and COL1 greater than commercially available DDM (CADDM), which can induce more osteoblast-like cell migration

  • These results demonstrated a release kinetic of proteins and osteoinductivity of CMDDM, which supports a benefit of using autogenous bone graft

Read more

Summary

Introduction

An estimated 2 million individuals worldwide suffer from bone defects due to trauma, infection, tumor, or congenital hereditary diseases caused by bony abnormalities. Bone grafts have been predominantly used to treat bony defects. Demineralized dentine matrix (DDM) is a kind of dentin which was demineralized and obtained from extracted teeth as a kind of bone graft material [4,5,6]. The structure and composition of dentin is similar to that of bone, consisting of collagen type I (COL 1) 20%, hydroxyapatite (HA) 70%, and body fluid 10% by weight [7,8]. Dentin is thought to have a high osteoconductivity since it is a natural mineralized tissue consisting of HA. Dentin matrix is expected to exhibit osteoinductivity because it contains bone morphogenetic proteins (BMPs) [8]. BMPs induced mesenchymal stem cells to migrate to a bone-forming site as well as induce their differentiation into an osteoblast to form bone [11,12]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call